跳至主要内容
临床试验/KCT0006114
KCT0006114尚未招募未知

Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial Infarction

Seoul National University Hospital0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19?(Year) 至 0No Limit(—)
性别
All

入选标准

  • Patients who received successful percutaneous angioplasty using DES or DCB for the causative lesion
  • (the criterion for successful angioplasty was defined as the case where the target coronary artery TMI III blood flow and residual lesion stenosis were less than 30%).

排除标准

  • 1) Ongoing end-stage heart failure or symptoms of heart failure (Killip class II or higher or left ventricular ejection rate <20% on echocardiography)
  • 2) Patients with uncontrolled ischemia such as repetitive pain or repetitive ischemic electrocardiogram changes
  • 3) Patients with uncontrolled ventricular arrhythmia
  • 4) Symptoms of malignant tumors in which myocardial infarction treatment is clinically insignificant
  • 5) Signs of a serious infectious disease
  • 6) Pregnant or lactating patients
  • 7) Participants in other clinical studies who disallow stem cell treatment for myocardial infarction (this treatment can be implemented if the patient voluntarily withdraws consent from other clinical studies)

研究者

相似试验